Time to watch: How Timber Pharmaceuticals (TMBR) shares jumped in the AH session
Timber Pharmaceuticals (NYSE: TMBR) rose 23.97% to $1.5 in the after-market session. This stock has wildly shifted this year, with buyers keen to raise stock rates for simple business news or no news at all. Nevertheless, on December 10, 2020, A biopharmaceutical corporation focusing on the production and commercialization of therapies for rare and orphan […]
